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Abstract 
Multimorbidity is an emerging topic in public health policy because 
of i ts increasing prevalence and socio-economic impact. However, 
the age- and gender-dependent trends of disease associations at 
f ine resolution, and the underlying genetic factors, remain 
incompletely understood. Here, by analyzing disease networks from 
electronic medical records of primary health care, we identify key 
condit ions and shared genetic factors influencing multimorbidity. 
Three types of diseases are outl ined: “central”, which include 
chronic and non-chronic condit ions, have higher cumulative risks of 
disease associations; “community roots” have lower cumulative 
risks, but inform on continuing clustered disease associations with 
age; and “seeds of bursts”, which most are chronic, reveal 
outbreaks of disease associations leading to multimorbidity. The 
diseases with a major impact on multimorbidity are caused by 
genes that occupy central posit ions in the network of human 
disease genes. Alteration of l ipid metabolism connects breast 
cancer, diabetic neuropathy and nutrit ional anemia. Evaluation of 
key disease associations by a genome-wide association study 
identif ies shared genetic factors and further supports causal 
commonalit ies between nervous system diseases and nutrit ional 
anemias. This study also reveals many shared genetic signals with 
other diseases. Collectively, our results depict novel population-
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based multimorbidity patterns, identify key diseases within them, 
and highlight pleiotropy influencing multimorbidity. 
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Introduction 
Multimorbidity, defined as the co-occurrence of two or more diseases in a given 
individual, poses a major challenge to quality of care, and emerges as an 
important issue when considering activity and effort in health systems1,2. 
Multimorbidity is commonly associated with chronic conditions, but non-chronic 
or acute diagnoses, such as those related to falls, also contribute to its 
occurrence3. Chronic diseases are particularly relevant because of their rising 
prevalence and burden in aging societies, where they incur substantial costs to 
health care systems. In fact, the economic cost per multimorbid patient is 3-5 
times that of non-multimorbid cases4,5. As highlighted by the World Health 
Organization, chronic diseases have reached epidemic proportions and 
constitute the leading causes of death in the world6. In Europe, an estimated 50 
million people —approximately 7% of the total population— suffer from 
multimorbidity7. This percentage is even higher (>55%) among the elderly8. 
Even so, health systems do not meet the needs of multimorbid patients; the 
structures are typically “disease oriented” and “non-integrative”. Thus, care is 
generally organized around specific medical specialties, an approach that leads 
to fragmentation, which, in turn, may lead to over-prescription, over-
hospitalization, and poor patient satisfaction9,10. Therefore, there is a clear need 
to improve care for individuals with multimorbidities, but this requires a much 
more detailed understanding of the trends of disease associations than we 
currently possess. In addition, there is a need to identify genetic factors 
influencing multimorbidities, which might then constitute new tools for clinical 
prevention and monitoring. 
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To date, the study of age- and gender-dependent disease associations at 
the population level has mainly focused on chronic1,11 and/or specific12,13 
conditions. Broader disease analyses have been performed, but have centered 
on high-order classifications14, the elderly15, and/or relatively small cohorts2. 
Network-based approaches have the potential to uncover unexpected 
relationships between diseases14,15,16,17,18,19,20,21,22. To apply these approaches, 
systematic and detailed high-quality clinical annotations of a large number of 
individuals are required. In parallel, collection and analysis of biological samples 
in the same population can provide the means to identify shared genetic factors 
among diseases linked to multimorbidity23,24. Here, by constructing and 
analyzing disease networks from high-quality primary heath care data, and by 
integrating the results with genome-wide association studies (GWASs) of 
individuals from the same population, we identify key diseases, their cumulative 
risk trends and genetic factors influencing multimorbidity. 
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Results 
Disease networks built from primary health care data 
A dataset from the electronic primary health care records of Catalonia, a 
Mediterranean region with more than seven million individuals, was analyzed for 
age- and gender-centered disease network topological properties that may be 
associated with multimorbidity and/or pleiotropy (Fig. 1a). This primary health 
dataset, known as SIDIAP-Q, comprises records from the universal coverage 
health care system and high-quality clinical annotations based on validated 
scores25,26. Patient diagnoses were based on the International Statistical 
Classification of Diseases and Related Health Problems, 10th revision (ICD-
10)27. A total of 1,749,722 individuals (23.5% of the Catalan population) aged at 
least 19 years and with two or more open recorded diagnoses between 1st 
January and 31st December 2010 were grouped by 5-year intervals or strata 
(from 19-24 to ≥ 90 years old) and by gender, and included in this study 
(Supplementary Fig. S1a). To investigate the impact of diseases and 
multimorbidities that are most relevant to the general population, we only 
considered diagnoses with a prevalence of ≥ 1% (Supplementary Table S1) 
and that were associated with any other disease by a measure of comorbidity 
strength (hereafter relative risk (RR)15,28) included in the bottom or top five 
percentiles across the 15 age strata of men and women. These thresholds 
corresponded to RR estimates of < 0.8, which suggests mutually exclusive 
diseases, or > 1.6, which suggests co-occurring or comorbid diseases, 
respectively, across all the strata (Supplementary Fig. S1b and 
Supplementary Table S2). The RR estimates were positively correlated 
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(Spearman’s correlation coefficient (ρ) = 0.82 – 0.88, P < 10-16) with the Jaccard 
index, a statistic frequently used to measure the similarity of sample sets. 
However, this index is not appropriate for relatively rare observations and 
cannot distinguish between different directions of association29. 
For each stratum, a network of morbidities was derived in which nodes 
represent diseases and edges represent RRs. The main network components 
included more than 70 nodes or nosological entities, and 300 edges or disease 
associations (Fig. 1b). Except for the elderly, these components were found to 
be bigger in women, which is consistent with a higher prevalence of female 
multimorbidity2,10. The cumulative distributions of the number of edges by nodes 
(degree (k) distribution) revealed exponential decays (Fig. 1c). This is a similar 
pattern to that of mortality following emergency medical admission30 and is 
inversely related to epidemic spread31. In addition, all observed morbidity 
networks exhibited a predictable property of ‘small-world-ness’32 
(Supplementary Fig. S2), by which most nodes or diseases can be reached 
from every other node through a relatively small number of edges33. Therefore, 
the constructed disease networks are coherent with previous knowledge and 
reveal expected systems-level features. 
 
Clinical coherence of the disease networks 
To assess the clinical coherence of the networks, we performed 1,000 
permutations of the associated (based on RRs) ICD-10 codes in each stratum 
and computed the proportion of code pairs sharing a higher-level clinical 
classification or chapter; there were 21 of these27. In all strata and for both 
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genders, none of the random sets showed a higher proportion of shared clinical 
chapters than that of the real networks (Fig. 1d). Next, the clinical coherence 
of the networks was evaluated using the functional and molecular interactions of 
the underlying genes and/or proteins (genes/proteins). The ICD-10 codes were 
linked to the genes/proteins associated to each condition based on the 
phenotype-genetic associations from the Online Mendelian Inheritance in Man 
(OMIM)34. We hypothesized that coherent disease associations frequently show 
relatively small shortest interaction paths between the underlying 
genes/proteins. Thus, approximately 78% of the diseases with an OMIM 
annotated gene/protein included in a molecular network showed at least one 
disease association with a smaller shortest path than randomly expected, and 
there was no bias with respect to prevalence differences (Fig. 1e). Therefore, 
the disease networks are also coherent based on higher order clinical 
annotations and phenotype-genetic associations. 
 
Identif ication of central diseases 
Having established their coherence, we analyzed the networks in order to 
detect diseases with a major impact on multimorbidity. A modified version of the 
PageRank35 algorithm was applied to take into account the edge weights 
indicated by the RRs (see Methods). Thus, 13 and 17 diseases appeared at 
least four times among the 10 most central diseases across the strata in men 
and women, respectively (Fig. 2a). Seven diseases (including chronic and 
non-chronic conditions) were common to both genders and comprised critical 
diagnoses across different ages, such as “Disorders of adult personality and 
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behavior” (Fig. 2a). Non-chronic, acute conditions, such as injuries and 
infections, also proved to be central in several strata, building on previous 
observations in older patients3. 
Visual inspection of the networks highlights the central nodes as being 
those with multiple edges more frequently linking different “communities” 
(subsequent section); diseases that are highly prevalent in the population, like 
“Diabetes mellitus”, also have a relatively large number of edges, but these are 
mainly linked to diseases in the same community (Fig. 2b). Nonetheless, 
consistent with epidemiological observations36, the strongest association with 
“Diabetes mellitus” corresponded to “Polyneuropathies and other disorders of 
the peripheral nervous system” (RR = 3.73, P < 10-16), and this condition 
emerged as central in this study (Fig. 2a,b). According to their topological 
feature, deletion of central nodes led to a higher number of network components 
than that of randomly expected in 3/15 and 12/15 of the male and female 
disease networks with edges of RRs > 1, respectively. Conversely, no such 
impacts were observed when central nodes were deleted in networks including 
only edges of RRs < 1 (Supplementary Fig. S3). Collectively, the above 
data identify chronic and non-chronic conditions with a potential major role in 
multimorbidity. 
 
Main disease communities 
To analyze the patterns of disease aggregations, densely connected sets of 
nodes or network communities appearing in at least two consecutive strata 
were identified. The diseases commonly present across the strata comprised 
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the “roots” of the communities. Thus, recognized temporal patterns associated 
with gender-specific diseases were observed: for instance, cancer-associated 
communities were identified spanning the 45-64- and 55-74-year-old groups for 
women and men, respectively (Fig. 2c and Supplementary Table S3). This 
analysis also highlighted disease communities that may require further health-
care efforts based on their sustained presence over time, in particular, a 
community with root “Injuries and consequences of external causes” in men 
aged 45-64 years, and a community with root “Mental, behavioral and 
neurodevelopmental disorders” in women aged 65-90 years (Fig. 2c). 
Therefore, community-aggregated diseases identify specific multimorbidity 
patterns, providing a means for following up clustered associations with age. 
 
Unexpected bursts of disease associations leading to 
multimorbidity 
The progression of cumulative disease associations was further analyzed at the 
level of node degrees. The number of edges (considering only RRs > 1.6) per 
node was computed across all strata, and nodes with relatively large leaps in 
their degree (k) were identified; i.e., representing a large increase in the number 
of associations for a given disease, from a younger to an older stratum. This 
analysis revealed 19 and 27 nodes in men and women with leaps of k ≥ 10, 
respectively, and these included 10 diseases common to the two genders (Fig. 
3a and Supplementary Table S4). To assess the significance of these 
multimorbidity bursts, the results were compared with those of 1,000 equivalent 
random networks in each stratum and gender, preserving the degree 
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distribution and connectedness of each corresponding real network. 
Remarkably, none of the random networks showed a distribution with a greater 
or equal number of large-degree leaps than the real networks (one-sided 
Pempirical < 0.001; Fig. 3b). Four and seven of the 19 and 27 aforementioned 
diseases, respectively, were previously classified as central, and two were 
present in both genders: “Complications of surgical and medical care, not 
elsewhere classified” and “Polyneuropathies and other disorders of the 
peripheral nervous system” (Figs. 2a and 3a). Therefore, particular diseases, 
some of which also play a central role in networks, act as seeds for 
multimorbidity. 
Most of the bursts (72% (26/36) in men and women) corresponded to 
chronic conditions acting as seeds (Fig. 3a and Supplementary Table S4). 
However, the non-chronic diagnoses “Complications of surgical and medical 
care, not elsewhere classified” and “Falls” also emerged in this analysis in both 
genders (Fig. 3a). The former condition suggests that prevention of 
multimorbidity in primary health care should take into account surgical 
interventions in hospitals. In addition, the identification of “Falls” is consistent 
with the findings of recent epidemiological studies in the elderly37,38, so 
monitoring these acute conditions could further improve the management of 
multimorbidity bursts, particularly in middle-aged women, as suggested by our 
study (Fig. 2a).  
 
Trajectories of cumulative risks 
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The results above have shown unexpected bursts of disease associations that 
may have an important role in the emergence of multimorbidity. However, it 
remains unknown if there are differential trends of cumulative disease 
associations among the different types of network nodes. The progressive 
aggregation of diseases was evaluated by analyzing the trajectories of the sum 
of all RRs for each disease as a function of age. This analysis was independent 
of the initially defined RR thresholds and considered all diseases with ≥ 1% 
prevalence. While the sum of RRs < 1 (using their inverse value, 1/RR) revealed 
mostly flat or smoothly decreasing profiles in both genders, substantial 
increasing trends were observed for summed RRs > 1 (Supplementary Fig. 
S4). To assess differences in the trends, the 95% confidence interval (CI) 
estimates of each RR sum distribution were computed; thus, the trends for 
women and men did not overlap for most of the age groups (Fig. 4a). Women 
had higher average RR sums, but men, particularly those aged 30-64 years, 
had a steeper slope (Fig. 4a). A coincidence test indicated that all four 
distributions (by gender and/or effect) were significantly different (P ≤ 0.001). 
Remarkably, the global increase of summed RRs > 1 was found to be 
approximately 60% and 40% in men and women, respectively, further 
highlighting the relevance of multimorbidity. 
Next, the trends of the disease sets classified above as central, 
community roots, or with large degree leaps were analyzed. Consistent with 
their key role in multimorbidity progression, the central diseases in men and 
women showed higher RR sums than all other diseases (Pcoincidence ≤ 0.002; 
Fig. 4b). Again, women had higher sums, but the slopes were steeper in men 
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(Fig. 4b). Building on these observations, analysis of the global correlation 
between the average centrality of each node across all the networks, and the 
difference between the minimum and maximum RR sum of each disease across 
all strata, revealed a positive association in men (ρ = 0.27, P = 0.007; Fig. 4c). 
Therefore, node centrality in male disease networks is linked to its relative 
importance in accumulating disease associations with age. The equivalent 
analysis in female networks did not reveal a significant association, possibly 
due to the lower minimum-maximum cumulative risk difference (Fig. 4a). 
Subsequently, opposite of what was seen for the central diseases, but 
consistent with the network topology, the diseases identified above as 
community roots had lower RR sums than did all other diseases, particularly in 
women (Pcoincidence < 0.001 relative to central; Fig. 4d). However, diseases that 
are seeds for multimorbidity bursts (excluding those that are also central) also 
had a higher cumulative risk of comorbidities (Pcoincidence ≤ 0.002 relative to 
roots; Fig. 4e). These results were corroborated using the cumulative average 
of RRs for each disease (Supplementary Fig. S5). Therefore, network-
based features identify different types of diseases relative to their cumulative 
risk leading to multimorbidity. 
 
Centrality and pleiotropy l inked to causal genes 
The identified diseases underlying multimorbidity —particularly those linked to 
network centrality and/or bursts of disease associations— may be caused by 
genes that, as a consequence, influence multiple human disorders. To test this 
hypothesis, we analyzed a curated human disease gene network in which two 
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genes are connected if they are causative of the same disease39. Using this 
independent dataset and two different measures of network centrality, the 
causal genes of the central and burst-seed diseases were found to be more 
central than that of the community-root diseases in both genders (Mann-
Whitney P values < 0.001) (Fig. 5a). Intriguingly, the causal genes of 
community-root diseases were also found to be more central than that of the 
rest of diseases (Mann-Whitney P values < 0.001) (Fig. 5a), which further 
highlights the link of these conditions with major disease aggregations through 
age (Fig. 2c). Topological analyses of the corresponding gene products in a 
curated interactome network40 also revealed that all three sets (i.e, central, 
burst-seed, and community-root) have higher centrality than that of other gene 
products (Supplementary Fig. S6). Interestingly, the three gene product sets 
did not show differences among them (Supplementary Fig. S6), which might 
denote a non-lineal relationship between genetic causality and diversity of 
protein function. 
As indicated above, one condition emerged as relevant in both the 
centrality and burst analyses: “Polyneuropathies and other disorders of the 
peripheral nervous system”. This condition had fewer recognized associations 
with “Malignant neoplasms, stated or presumed to be primary” and “Nutritional 
anemias” in women (Supplementary Table S4). Following on these 
observations, the concordance of gene expression alterations underlying the 
three diseases was assessed41,42,43. Higher overlaps than expected by chance 
were observed between the gene expression signatures from the three 
diseases (χ2 = 9.2; one-tailed P < 0.002). Genes involved in lipid metabolism 
	 15	
were found to be common to all three diseases (Supplementary Table S5). 
By contrast, no significant overlap was found when compared to differentially 
expressed genes in lung adenocarcinomas44. Furthermore, the expression 
scores for the signatures characteristic of undernutrition42 and diabetic 
neuropathy43 were found to be negatively correlated with age at diagnosis of 
breast cancer (Fig. 5b). Therefore, the central and burst-seed diseases are 
caused by genes that in turn play a central role in the human disease gene 
network, and we provide evidence of shared gene expression alterations 
between diabetic neuropathy and undernutrition that promote breast cancer. 
 
Shared genetic factors among diseases l inked to multimorbidity 
To further evaluate disease associations at the level of shared genetic factors, a 
GWAS was performed in the same population as the SIDIAP-Q disease 
networks study (Genomes for Life)45. This investigation focused on central 
diseases with detailed clinical definitions and on common diagnoses with more 
than 200 cases included in the cohort (three and nine diseases, respectively; 
Supplementary Table S6). The application of a genome-wide association 
pairwise approach46 revealed that central diseases tended to share, on 
average, a greater number of significantly associated variants than the nine 
common diseases (20 vs. 11 significant signals). Subsequently, seven of the 36 
possible non-redundant disease pairs showed a higher number of shared 
variants than that of 100 random GWASs (Fig. 6a). Importantly, these seven 
pairs corresponded to RRs > 1.5 (P < 10-3) across at least two strata in both 
genders, which reinforces their epidemiological relevance. 
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Besides expected overlaps (e.g., shared signals between “Diabetes 
mellitus” and “Disorders of lipoid metabolism” or “Essential (primary) 
hypertension”), there were shared genetic associations between “Nutritional 
anemias” and “Diseases of the nervous system” (Fig. 6a), which includes 
polyneuropathies. Thirty-one significant association signals were detected in 
this comparison and, notably, three of them were also found to be in linkage 
disequilibrium (LD, D’ > 0.99) with variants previously identified as influencing 
multiple human traits46,47 (Supplementary Table S7). Most importantly, 17 of 
the 28 remaining shared signals were found to be in linkage disequilibrium with 
GWAS results involving one or more other human disorders or traits 
(Supplementary Table S7). This proportion of 20/31 shared signals was 
found to be higher than the average proportion of 100 sets of 31 randomly 
chosen genetic variants (Pempirical ≤ 0.01; Fig. 6b). The neighbor genes of these 
pleiotropic signals were found to be significantly enriched (false discovery rate 
(FDR)-adjusted P = 2.1 x 10-7) in loci linked to smoking cessation versus 
dependence48. Intriguingly, smoking is an established lifestyle factor associated 
with multimorbidity49,50. Therefore, key disease associations linked to 
multimorbidity are influenced by shared genetic factors, which in turn may be 
associated with important lifestyle factors. 
None of the 31 signals appeared to be an expression quantitative trait 
locus (eQTL) when exploring the GTEx database (v6.0)51. However, when 
variants in LD were considered, the expression of 17 genes may be associated 
(Supplementary Table S8). Notably, seven of these genes were found to be 
altered in thyroid tissue, which represents a higher number than expected by 
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chance (P = 9 x 10-6). This observation may be in concordance with 
observational studies in animals and humans linking impaired thyroid 
metabolism to iron-deficiency anemia52. In addition, thyroid deregulation 
(underactive thyroid) is a risk factor for peripheral neuropathy, which overall 
provides a tissue-based mechanistic hypothesis for the observed multimorbidity 
and pleiotropy. 
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Discussion 
Our results show that specific topological features of disease networks identify 
conditions with a key role in the emergence and/or progression of multimorbidity 
in the general population. The causal genes of these key conditions also occupy 
central positions in the network of human disease genes, which is consistent 
with their predicted pleiotropic effects. In addition, this study reveals shared 
genetic factors among diseases linked to certain multimorbidities and, in 
particular, highlights associations between breast cancer, diabetic neuropathy, 
and nutritional anemia, and between diseases of the nervous system and 
nutritional anemias. 
Three types of diseases are identified in this study: central, which include 
chronic and non-chronic conditions, accumulate relatively higher risk of 
multimorbidity with age in both genders; “community roots”, which accumulate 
less risk, but indicate major disease aggregations with age; and “burst seeds”, 
which nucleate diagnoses for 10 or more conditions in a single individual. In the 
biomedical scenario, central diseases may be interpreted as those more likely 
leading to multimorbidity or with a higher probability of appearing in a given 
multimorbid patient. In an analogous manner, their causal genes have the 
potential to influence multiple diseases and, therefore, they may be functionally 
linked to different molecular process and/or signaling pathways53,54,55. A 
particular type of central disease with a key role in multimorbidity corresponds 
to those identified as “burst seeds”, which show a sharp accumulation of 
disease associations. The causal genes of this type of diseases may also 
harbor pleiotropic effects, but one can speculate that other biological, 
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environmental and/or lifestyle factors critically contribute to the observed burst 
effect. Finally, the function of causal genes for “community root” diseases may 
be more specific at the molecular, cellular and/or tissue level. 
The observed multimorbidity bursts are generally linked to chronic 
diseases and, thus, clinical studies of identified seed conditions may be able to 
improve prevention strategies and health care policies9,10. Nonetheless, two 
acute conditions (“Complications of surgical and medical care, not elsewhere 
classified” and “Falls”) also emerge as central and mediating bursts, so their 
integration in prevention could further help improve multimorbidity care, and not 
only in the elderly37,38. However, there are significant differences in the 
cumulative risk trends between men and women, which therefore should also 
be taken into account when preventing and/or managing multimorbidity. 
“Polyneuropathies and other disorders of the peripheral nervous system” and, 
again, “Complications of surgical and medical care, not elsewhere classified” 
appear to be particularly relevant in both genders. The identification of the latter 
is additional evidence that attention to multimorbidity in primary care should be 
coordinated with programmed activities in secondary and tertiary care3,56. In 
contrast to central diseases, network communities provide evidence to detect 
clustered aggregations across sequential age groups. Thus, community roots 
should not be the focus of cumulative risk analyses, but they can potentially 
assist in identifying the most frequent disease aggregations. 
Monitoring of individuals diagnosed with diseases identified in this study, 
in combination with analyses of pleiotropic factors, could potentially reduce the 
current impact of multimorbidity on health care systems. Crucially, our study 
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shows that the causal genes of central and burst-seed diseases occupy a 
central position in a genetic network of human disorders, which further endorses 
their relevance in multimorbidity. Therefore, analyses of these causal genes 
may be useful for monitoring and/or predicting multimorbidity. Specifically, lipid 
metabolism appears to be commonly perturbed in breast cancer, diabetic 
neuropathy, and nutritional alterations, which is also consistent with the 
proposed causal links between cancer, diabetes, and obesity57. At the germline 
level, our GWAS in individuals of the same population in which disease 
networks are studied has identified seven pairs of diseases with a significant 
number of shared genetic factors. These pairs include “Nutritional anemias” and 
“Diseases of the nervous system”, which are also linked to centrality and bursts 
in the network analyses. Of note, many of the genetic variants identified in this 
comparison are in linkage disequilibrium with variants associated with other 
human traits or diseases46,47, including smoking dependence48. This 
observation further reinforces the pleiotropic connection between the two 
diseases and others, and the possibility of identifying markers for estimating 
and/or preventing the risk of multimorbidity including those conditions. 
Prospective studies to address these questions may be warranted. 
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Material and Methods 
Design, sett ing and study population 
A cross-sectional study was conducted in Catalonia (Spain), a Mediterranean 
region with 7,434,632 inhabitants, 81% of whom live in urban municipalities 
(2010 census). The Spanish National Health Service (NHS) provides universal 
coverage, financed mainly by tax revenue. The Catalan Health Institute (CHI) 
manages primary health care teams (PHCTs) that serve 5,501,784 patients 
(274 PHCTs), or 74% of the population; other providers manage the remaining 
PHCTs. The CHIs Information System for the Development of Research in 
Primary Care (SIDIAP) contains the coded clinical information recorded in 
electronic health records by its 274 PHCTs since 2006. A subset of records 
meeting the highest quality criteria for clinical data (SIDIAP-Q) includes 40% of 
the SIDIAP population (1,833,125 individuals), attended by 1,365 general 
practitioners whose data recording scored highest in a validated comparison25. 
SIDIAP has been shown to be highly representative of the Catalan general 
population in terms of geography, age and gender distributions according to the 
official 2010 census. This study included individuals ≥ 19 years of age and 
assigned to a PHCT during the period of study (1st January - 31st December 
2010). The SIDIAP-Q study was approved by the Jordi Gol University Institute 
for Research Primary Healthcare (IDIAP) ethics committee and the GWAS by 
the Germans Trias i Pujol Health Sciences Research Institute (IGTP) ethics 
committee. Regarding SIDIAP and according to Spanish legislation about 
confidentiality and data protection (Organic Law 15/1999 of 13 December for 
the Protection of Personal Data), the data included in this database were 
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always anonymized; thus, it was not necessary to ask for informed consent to 
the participants. All the participants in the GCAT GWAS provided written 
informed consent. These studies followed national and international regulations 
for research involving human subjects: Declaration of Helsinki Ethical Principles 
for Medical Research Involving Human Subjects and Good Research Practice 
principles and guidelines. The SIDAP-Q data are available upon request and 
ethics committee approval, and GCAT GWAS data have been deposited in the 
European Genome-phenome Archive. 
Coding and selection of diseases 
Diseases are coded in SIDIAP using the ICD-1027. For this study, we selected 
all active diagnoses recorded in electronic health records as of December 31st 
2010, except for R (symptoms, signs, and abnormal clinical and laboratory 
findings, not elsewhere classified) and Z (factors influencing health status and 
contact with health services) codes. Non-active diagnoses, identified by the 
presence of an end date in the records, were excluded from the analysis. These 
diagnoses cover a broad list of acute diseases for which the system 
automatically assigns an end date (e.g., 60 days after the initial diagnosis). To 
facilitate management of the information, the diagnoses were extracted using 
the 263 blocks (disease categories) in the ICD-10 structure. These are 
homogeneous categories of very closely related specific diagnoses; for 
example, hypertensive diseases include “Essential (primary) hypertension, 
Hypertensive heart disease, Hypertensive renal disease, Hypertensive heart 
and renal disease, and Secondary hypertension”. From the 263 blocks, we 
excluded the R and Z codes, and 13 codes were not found in SIDIAP-Q, leaving 
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241 blocks suitable for analysis. To produce consistent and clinically 
interpretable networks based on binary disease associations, and to avoid 
inclusion of spurious relationships that could bias the results, we considered 
only diagnoses with ≥ 1% prevalence for each of the following age strata: 19-24, 
25-29, 30-34, 35-39, 40-44, 45-49, 50-54, 55-59, 60-64, 65-69, 70-74, 75-79, 
80-84, 85-89, ≥ 90 years, and for both genders. This minimum threshold of 
prevalence led to the analysis of 144 and 141 diseases in men and women, 
respectively. All patients with two or more coexisting diagnoses recorded on 31st 
December 2010 were included. 
Chronic and non-chronic definit ion 
Each diagnosis was classified using the O’Halloran criteria for chronic 
conditions in the International Classification for Primary Care-2 (CIAP-2)58. We 
included all 146 diagnoses considered as chronic diseases by these criteria: i) 
having a duration that has lasted, or is expected to last, at least six months; ii) 
having a pattern of recurrence or deterioration; iii) having a poor prognosis; or 
iv) producing consequences, or sequelae, that have a significant impact on 
quality of life. The diseases that did not meet these criteria were classified as 
non-chronic. The ICD-10 codes were mapped to identify chronic and non-
chronic diseases. All results were described using these codes. 
Relative risk computation and trends 
Categorical variables were summarized as frequencies (percentages); normally 
and non-normally distributed quantitative variables were summarized as means 
(standard deviations, SDs) and medians (interquartile ranges, IQRs), 
respectively. The relative risk (RR) was calculated to quantify the strength of 
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disease associations (comorbid if RR > 1 or tending to be mutually exclusive if 
RR < 1) as previously proposed15,28. The ratio is that of the observed 
prevalence of patients diagnosed with both diseases to the expectation based 
on the product of the corresponding disease prevalences. The RR 95% 
confidence intervals (CIs) and P values were obtained using the methods of 
Katz59, and Altman and Bland60, respectively. Generalized additive models 
(GAMs)61 using cubic splines as the smoothing function were fitted to estimate 
RR sum distributions over age groups, for RR > 1 and RR < 1 associations, 
stratified by gender. The 95% CI of each distribution was obtained from the 
standard error of the fitted model. Join-point models 
(https://surveillance.cancer.gov/help/joinpoint) were used to investigate the 
trends of RR sum distributions across age groups. Statistical differences in 
slope were assessed using the annual percent change (APC) test62. To check 
the similarity of any pair of RR sum distributions tests for parallelism and 
coincidence63 were conducted. The cumulative distributions of disease 
associations across age groups were evaluated using the RR and Jaccard 
index (particularly the 1-Jaccard) estimates, and three similar approaches: 1) by 
computing the sum of the association estimates for each disease in each 
stratum and gender; 2) by computing the average of the estimates for each 
disease in each stratum and gender; and 3) by computing the sum of the 
estimates for each disease in each stratum and gender, but considering only 
diseases with ≥ 1% prevalence and dividing the sum by the number of strata in 
which a given disease appears. The correlation relative to the network centrality 
values was computed using, for each disease, the difference between the 
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minimum and maximum of the cumulative estimate across age groups. The 
centrality values were normalized between 0 and 1, and the average value 
across all the networks was used for each disease. 
Network construction 
For each age group and gender (i.e., stratum), a network was built with nodes 
corresponding to diagnoses matching the criteria detailed above, and edges 
corresponding to comorbidity if the corresponding RR was included in the top or 
bottom vigintile of the overall distribution of RRs in a given stratum. These 
percentiles corresponded to RRs < 0.8 or > 1.6 across all strata. The SIDIAP-Q 
dataset linked the diagnoses in each stratum using the Jaccard index, Jij26. This 
index accounts for the similarity of two diagnoses di and dj, and takes values 
between 0 and 1. In parallel, the SIDIAP-Q dataset contained the frequency of 
the diagnoses, Ni and Nj, and the population number N for each stratum. From 
these data, RRs were computed as follows:  
𝑅𝑅!" = 𝐽!" 𝑁! + 𝑁! 1+ 𝐽!" 𝑁𝑁!𝑁!  
With the criteria of considering diagnosis with prevalence greater than 1%, and 
discarding disease associations based on their RR percentiles (> 5% and < 
95%), the networks contained between 73 and 111 diagnoses. The number of 
these diagnoses varied with age and gender, whereby more nodes were 
generally noted for women and for older age groups. 
Small-world-ness 
In order to assess the small-world-ness characteristic of the observed morbidity 
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networks, we used the method proposed by Humphries and Gurney32. The 
approach states that a small-world network fulfills the condition that 𝐿! ≥ 𝐿!"#$ 
and 𝐶!! ≫ 𝐶!"#$! , where L is the average shortest path length of the network and CΔ is the average clustering coefficient. The small-world-ness SΔ is introduced as 
follows: 
𝑆! = 𝐶!! 𝐶!"#$!𝐿! 𝐿!"#$  
Therefore, SΔ > 1 corresponds to a small-world network. In this study, we did not 
consider different weights for the network edges (i.e., all weights had a value of 
1). The 𝐶!"#$!  and 𝐿!"#$ values were, for each network, the average of 1,000 Gn,m 
random model sample values. The outcomes were SΔ > 1 for all observed 
networks and SΔ > 2 for the strata younger than 80 years of age. 
Node centrality 
The PageRank35 algorithm was used to compute node centrality in the 
networks. This algorithm assigns a weight to each node that ranks its 
importance among the global set of nodes of the network. A node that is 
related, either directly or through other nodes, to nodes with a high PageRank 
value receives a higher weight and is defined as more “central”. The PageRank 
can be considered a variant of the eigenvector and Katz centralities, and 
overcomes problems like the concentration of most of the centrality on a 
relatively small number of nodes64. The PageRank value of a node is defined 
recursively and determined by three main factors: the number of edges it 
receives and their weight; the number of edges of the neighbors; and the 
centrality of these neighbors. This ranking algorithm has a probabilistic 
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interpretation using the so-called Google matrix G65. For an undirected positive 
edge weighted graph, G is defined as follows:  
𝐺 = 𝛼𝑊𝐷!! + 1− 𝛼𝑛 𝐽 
Therefore, α is the damping factor, W is the weighted adjacency matrix of the 
network, D is the diagonal degree matrix defined by Dii = ∑j |Wij|, and J is the 
matrix of all ones. The matrix G is a left-stochastic Markov matrix —each 
column sums to one— and represents random walks in the network. The 
parameter (1 − α) is the probability of jumping randomly to any node in the 
Markov chain process without having to follow an edge between the nodes. The 
PageRank values are the entries of the dominant right eigenvector, which 
correspond to the steady-state of the Markov chain. The straightforward 
generalization of PageRank to signed weights, named signed spectral 
ranking66, raises a problem: G is no longer a stochastic matrix, so the 
probabilistic interpretation loses meaning. To resolve this limitation, we used a 
method that considers positive (G+) or negative (G-) weights67 to compute 
PageRank values for each sub-graph PR+ and PR-, respectively, thereby 
obtaining the final rank vector as MPR = PR+ − PR-, where MPR stands for the 
Modified PageRank. The damping parameter is usually assumed to be α ≈ 0.85 
for technical and social networks. As there is no established guideline for setting 
this value, we used α = 0.5 to take into account the fact that nodes represent 
blocks of diseases. Different values of α might change the order of the ranking, 
but high-ranked nodes persist. The human disease gene network was built 
using DisGeNet curated gene-disease associations (version 5.0)39. The 
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distance matrix between all vertices was computed and closeness centrality 
determined for each vertex as the inverse of the average distance to all other 
vertices. The eigenvector centrality was computed using the package NetworkX 
v2.1. All computations were performed using Python v2.7. Similar analyses 
were performed using the Agile Protein Interactomes DataServer (APID) level 2 
dataset, which includes protein interactions proven by two or more 
experiments40. 
Community detection 
It is assumed that a community (or clustering) division separates the nodes of 
the network into groups such that connections are stronger or more frequent 
within groups than between them. This study took a heuristic approach based 
on the maximization of modularity, a commonly used community quality 
measure. Modularity, Q, is a function representing the difference between the 
total edge weight in sets of the network under study and the total expected 
weight in the same sets from a random network generated by a given null 
model:  
𝑄 = 12𝑚 𝐴!" − 𝑃!" 𝛿!!,!!!!  
where m is the number of edges in the network, Aij is the (i, j) element of the 
adjacency matrix, Pij is the null term, and δσi,σj is the Kronecker δ between the 
communities of nodes i and j, that is σi and σj, respectively. With the correct 
choice of the null model it is possible to incorporate specific features of the 
network structure. A standard choice is Pij = kikj/2m, where ki and kj are the 
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degrees of nodes i and j, respectively68. For a weighted signed network, the 
modularity function Q can also be defined using the appropriate null model. This 
model should take into account the so-called “resolution limit”: modularity 
optimization might fail to identify small communities. The resolution scale 
depends on the total size of the network and the interconnectedness of the 
communities. A possible solution to this problem is to scale the signed null 
model by introducing parameters γ+ and γ-. The former equation then becomes:  
𝑄 = 12𝑤! + 2𝑤! 𝑊!" − 𝛾!𝑤!!𝑤!!2𝑤! − 𝛾!𝑤!!𝑤!!2𝑤! 𝛿!!,!!!!  
where W is the signed weighted adjacency matrix of the network,  
𝑊 = 𝑅𝑅!" ∈ ℝ!×! 
with 
𝑅𝑅!" = 𝑅𝑅!" if 𝑅𝑅!" > 1−1 𝑅𝑅!" if 𝑅𝑅!" < 1 
wi+ and wi- are signed generalized degrees from 
𝑤!! = max 0,𝑊!"!  𝑤!! = max 0,−𝑊!"!  𝑤! = 𝑤!! − 𝑤!! 
and the values of γ+ and γ- determine the importance assigned to the null 
network. Increasing γ+ enables smaller communities to be detected. On the 
other hand, smaller groups of nodes can be detected by decreasing γ-. A 
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method for estimating the best values of γ+ has recently been described69 and it 
is extended in this study to estimate γ-. The community configuration σ is 
obtained by maximizing Q. The number of possible community configurations in 
a network of n nodes is given by the Bell number, which grows exponentially 
with n. This is an NP-hard problem70, so heuristic algorithms are required. This 
study employed a method known as “spin glass community detection”71, an 
approach from statistical physics and based on the Potts model. In this model, 
each particle can be in one of several spin states, and the interactions between 
them determine which particles would prefer to have the same spin state. The 
analogy links particles with nodes, interactions with edges, and communities 
with the spin states. One aims to minimize the energy of the system, denoted by 
the Hamiltonian H, in order to find the ground state. It is known that the ground 
state is the most stable configuration of the system, and hence a cohesive 
community structure. An extension of the spin glass method to signed weighted 
networks was implemented in python-igraph for use in this study. The 
Hamiltonian H, which rewards internal positive and absent negative edges, and 
penalizes absent internal positive and internal negative edges72, is given as:  
ℋ = − 𝑊!" − 𝛾!𝑤!!𝑤!!2𝑤! − 𝛾!𝑤!!𝑤!!2𝑤! 𝛿!!,!!!!  
The Hamiltonian H and the modularity Q are related by  
𝑄 = − 12𝑤! + 2𝑤!ℋ 
and, consequently, minimizing H implies maximizing Q. The algorithm 
implemented uses a classical simulated annealing method73 to solve the 
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combinatorial problem. This technique can find a good solution, even when 
there is some noise in the data. Using a probabilistic process, it approximates 
the global optimum of the given function. 
Community independence and roots 
To qualitatively rank the degree of independence of a community we used an 
adaptation of the degree centrality that relies on 𝑅!" to reward a community for 
its negative interactions with the other communities and to penalize it for 
positive interactions. The method is detailed by the following equation, where 
higher values imply greater independence: 
𝐼 𝜎! = 1𝑛! −sign 𝑊!" 𝑊!" 𝛿!!,!! 1− 𝛿!!,!!!!  
Therefore, 𝐼(𝜎!) accounts for the independence of community 𝜎!, 𝑛! 
corresponds to the number of nodes in the community, 𝑊!" is the signed 
weighted adjacency matrix, and 𝛿!!,!! is the Kronecker δ of communities 𝜎! and 𝜎!. A root was defined by the detection of at least two nodes in a given 
community across a minimum of two consecutive strata. The three highest 
ranked/most independent (as defined above) communities in each stratum were 
analyzed. 
Coherence of disease pairs 
The biological coherence of the morbidity associations was assessed by 
analyzing the shortest path distance in a high-quality network of molecular 
interactions15 between genes and/or proteins (genes/proteins) assigned to 
diseases, then comparing the results with those of random genes/protein pairs. 
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Causal genes/proteins were assigned on the basis of phenotype-genetic 
annotations extracted from the OMIM74 database. The OMIM annotations were 
linked to ICD-10 diagnoses using Metathesaurus included in the Unified Medical 
Language System (UMLS) version 2015AB75. All the diseases with at least one 
causal gene/protein were included in the analysis; 111 diseases had at least 
one causal gene/protein, of which 104 had at least one causal gene/protein 
represented in the molecular network. For each disease pair present in the 
observed male or female morbidity networks, we computed the average 
shortest path between their causal genes/proteins (e.g., shortest path between 
gene/proteini and gene/proteinj corresponding to the associated diseases i and 
j, respectively) and compared the result with the average of 1,000 gene/protein 
pairs for which one of the members was randomly chosen and the other was a 
defined casual gene/protein. OMIM diseases frequently have more than one 
causal gene/protein and so we computed the average shortest path between 
the assigned genes/proteins. The morbidity networks included 1,051 and 1,031 
disease associations by RRs > 1.6, and 239 and 206 disease associations by 
RRs < 0.8 in men and women, respectively, with OMIM-assigned causal 
genes/proteins. Thus, for each of these associations, we computed the average 
shortest path and compared the result with that of 1,000 random 
genes/proteins, thereby obtaining empirical P values. The analysis was 
performed using the complete interactome dataset compiled by Menche et al.15 
or a subset corresponding to interactions with evidence from the literature and 
binary protein-protein assays. 
Degree leaps 
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To find leaps in the degree (k) of nodes through time, we constructed 
connectivity trajectories. For each diagnosis, we differentiated between edges 
corresponding to RRs > 1.6 or RRs < 0.8. Given a diagnosis or node, its 
connectivity trajectory for RRs > 1.6 was built as follows: for each age stratum, 
the number of connected edges with RRs > 1.6 was counted and the 
connectivity trajectory was the result of the number of edges across strata. 
Therefore, the leaps were defined based on the difference between the 
maximum and minimum k values of each node. Nodes with no change in their k 
across the age groups where they appear and nodes with spurious changes (a 
single change with no continuation in subsequent strata) were not considered in 
this analysis. To assess the observed distributions of leaps of disease 
connectivity across age in men and women, we generated random undirected 
networks that preserved the original node degree distributions and 
connectedness. The latmio_und function (Brain Connectivity MATLAB Toolbox; 
https://sites.google.com/site/bctnet/) was used for this analysis. Randomization 
was carried out using the “rewiring” parameter corresponding to the exact 
number of nodes in each observed network in the analysis. Thus, 1,000 random 
networks for each age group and gender were generated and combined 
(consecutively, one random network from each age group/gender) to obtain 
1,000 random distributions of disease connectivity leaps, which were compared 
with the observed values. 
Gene set overlap, gene expression and pathway enrichment 
The overlaps with the diabetic neuropathy and undernutrition gene expression 
signatures were computed using 2x2 contingency tables and the χ2 test with 
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Yate’s correction, considering an approximate total of 18,500 annotated human 
genes (the actual number varying by study). Pre-processed and normalized 
RNAseq data of normal breast tissue and primary breast tumors were taken 
from The Cancer Genome Atlas (TCGA) repository (Data Access Committee 
project #11689). A paired t-test was applied to detect differentially expressed 
genes between the normal tissue and tumors, and in the overlap analysis we 
only considered the genes corresponding to a false discovery rate (FDR) of < 
1%. The Reactome enrichment tool76 was used with standard parameters to 
detect significant pathways with a FDR < 5%. The expression signature scores 
were computed using the ssGSEA algorithm77 with standard parameters and 
using all genes included in each signature. The linear correlation analysis 
between the signature scores and age at diagnosis was adjusted by tumor 
stage. The association between pleiotropy and smoking cessation/dependence 
gene targets was based on PubMed enrichment analysis using the DAVID 
tool78. 
GWAS analyses 
The GCAT project includes a large prospective cohort from the Catalan general 
population with ages ranging between 40 and 65 years, baseline 
epidemiological characterization, and electronic health record-linked data45,79. 
For this study, we used baseline data at recruitment (2014-2016) for a subset of 
subjects. The participants (n = 5,459; GCATcore) were genotyped using the 
Expanded Multi-Ethnic Genotyping Array (MEGAEX) (Illumina). Genotyping was 
performed at the Genomics Unit IMPPC-IGTP. Extended quality control protocol 
is available at www.genomesforlife.com/GCATCoreAnalysis. After filtering, 
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4,988 participants and 1,652,023 genetic variants were included in the analysis. 
Sexual and mitochondrial chromosomes were discarded as well as autosomal 
chromosome variants with minor allele frequency (MAF) < 0.01 and AT-CG 
sites. Imputation used 665,592 (40%) variants and was performed using Shape-
IT80 and IMPUTE281 and four reference panels: 1000 Genomes, Genome of the 
Netherlands, UK10K, and Haplotype Reference Consortium. All variants with 
imputation correlations < 0.7 were removed. The best score was used for those 
variants present in more than one reference panel. Variant dosage from 
IMPUTE2 was transformed to binary PLINK82 format by using the “hard-call-
threshold 0.1” flag. The final core set was produced by approximately 15 million 
variants with MAF > 0.001 and 9.5 million variants with MAF > 0.01. Imputation 
was done at the Barcelona Supercomputing Center (BSC). Clinical conditions 
were defined from a self-reported questionnaire at baseline; 159 conditions 
were identified, occurring in 1 to 985 cases, 17 of these were collected by direct 
query, and some were identified from the open text field query. All reports were 
curated and mapped to ICD-10 codes. The diagnoses with more than 200 
cases included: allergies, arterial hypertension, asthma, depression, dermatitis, 
hyperlipidemia, migraine, rhinitis, and type II diabetes. The analysis for 
association signals influencing these diagnoses comprised two consecutive 
steps: an individual GWAS analysis for each ICD-10-based disease and then a 
pairwise analysis to detect shared associations. The GWAS summary statistics, 
with quality control protocols and data are available at the GCAT website, and 
the raw data have been deposited at the European Genome-phenome Archive83 
(access is regulated by GCAT Data Access Committee applications). The 
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analyses were performed using the score test and saddlepoint approximation in 
the SPAtest R package84. This method accounts for unbalanced case-control 
designs, as was the case in our study. The 20 first dimensions of the principal 
component analysis of population substructure, gender and age data were 
included as covariates in all analyses. The variants with a nominal value of P < 
0.05 in any of the considered single disease analyses were selected for 
pairwise analysis using the GWAS-pw tool46. This tool provides Bayes factor 
calculations and identifies variants that are shared in pairs of traits. Statistical 
power is assessed using a log Bayes factor > 685 and posterior probability > 0.7. 
In addition, the level of significance of each comparison was inferred empirically 
from 100 random GWAS-pw tests, based on 10 independent simulated datasets 
of each pair of conditions. For the comparison between “Nutritional anemias” 
and “Diseases of the nervous system”, to determine the random frequency of 
variants in linkage disequilibrium (D’ > 0.99 and P < 0.05 in the Iberian 
population of Spain) with GWAS signals of any human trait, we generated 100 
random sets of 31 variants (genome version hg19 and minor allele frequency > 
0.01) and subsequently computed their degree of linkage disequilibrium in the 
same 1,000 Genomes population against variants from the GWAS catalog 
(v1.0.1, 2018-02-28)86 over a range of ±100 kb. 
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Figure Legends 
Figure 1. Study design and disease networks. (b) Strategy for the 
identification of diseases and genetic factors influencing multimorbidity. Network 
nodes and edges correspond to diseases and relative risks (RRs), respectively, 
and were constructed using primary health records from the Catalan general 
population. (c) Exponential decay of cumulative degree (k) distributions of two 
example disease networks as depicted. (b) Distributions of the number of nodes 
and edges in each main network component across strata and by gender. (c) 
Exponential decay of cumulative degree (k) distributions of two example 
disease networks as depicted. (d) Proportions of linked ICD-10 codes that 
share a clinical chapter; box-plots show the results of 1,000 permutations and 
the observed value for each stratum network is indicated by a dot. (e) Number 
of diseases with causal genes/proteins included in the molecular network that 
revealed at least one disease association with a smaller shortest path than 
expected at random. The ordered orange bars indicate the number of disease 
associations that match this criterion for each disease (ICD-10 codes are 
indicated on the x-axis). The grey zone indicates diseases that do not match the 
criterion. A prevalence threshold is also depicted. 
 
Figure 2. Central diseases and network communities. (a) Diseases 
emerging as topologically central in men and/or women. The number of 
appearances (in different strata), the corresponding ages, and the specific 
condition (chronic or non-chronic) are shown. The dotted lines indicate diseases 
found to be common to men and women. (b) Disease network for women aged 
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65-69 years and depicting diseases (ICD-10 codes) identified as central in this 
gender. The node corresponding to “Diabetes mellitus” (not central) is also 
indicated (blue font). The node sizes reflect centrality value and their colors 
indicate communities (not shown). Edge thickness is proportional to the 
magnitude of the RR estimation; black indicates RR > 1.6 and green indicates 
RR < 0.8. Disease prevalence is shown by font colors as indicated in the inset. 
(c) Network communities appearing in at least two consecutive strata in men or 
women. The disease roots of each community are depicted in the insets. 
 
Figure 3. Multimorbidity bursts. (a) Age-based trajectories of nodes with 
large degree leaps; ≥ 10 edges (RRs > 1.6) over time. The left and right panels 
show results for men and women, respectively. The corresponding diseases are 
listed below each graph, and their chronic or non-chronic status is also shown. 
(b) Distribution of connectivity leaps in 1,000 random networks with the same 
degree distribution and connectedness as that of the real morbidity networks 
with RRs > 1.6. The y- and x-axes depict the probability and number of nodes 
with leaps of ≥ 10 edges, respectively; red arrows indicate the values observed 
in the real networks. 
 
Figure 4. Cumulative risk trends. (a) Average and 95% CI of RR sums by 
gender and age group. The dotted lines indicate slopes significantly different 
from zero. (b) Average and 95% CI of RR sums of diseases identified as central 
in the networks or as other, non-central diseases. The arrows indicate the 
cumulative risk differences between central and non-central diseases in men 
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(60 years) and women (65 years). (c) Graph showing the correlation between 
the average centrality value of each node across all networks in men, and the 
difference between the minimum and maximum RR sums of each disease. The 
linear trend and 95% CI (shaded area) are shown. (d) Average and 95% CI of 
RR sums of diseases identified as network community roots or other diseases 
(i.e., non-roots). The arrow indicates the cumulative risk difference between 
non-root and root diseases in women (65 years). (e) Average and 95% CI of 
RR sums of diseases identified as having large degree leaps (≥ 10 edges, and 
excluding those that are also central) or other diseases. The arrows indicate 
cumulative risk differences between disease sets with large leaps and no large 
leaps in men (55 years) and women (60 years). 
 
Figure 5. Centrality and pleiotropy l inked to causal genes. (a) 
Graphs showing the distributions of closeness and eigenvector centrality 
measures for different types of causal genes as indicated in the insets. The 
results correspond to the analysis of the curated human disease gene network 
and are shown for men and women disease sets derived from the SIDIAP-Q 
networks study. (b) Scatter plots depicting the negative correlations between 
the gene expression signatures (all genes included) that define diabetic 
neuropathy (left panel) or undernutrition (right panel) and age at diagnosis of 
breast cancer. The stage-adjusted linear regression coefficients and their 
corresponding P values are shown.  
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Figure 6. Shared genetic factors among diseases l inked to 
multimorbidity. (a) Matrix depicting pairs of central (blue) and common 
(green) diseases, and instances with a significant number of shared genetic 
variants relative to random GWASs (numbers of variants are shown). The 
corresponding RRs are shown for instances linking central diseases. (b) 
Distribution of shared genetic variants (also considering those in linkage 
disequilibrium) among 100 random sets of 31 variants and observed value of 
shared signals between “Nutritional anemias” and “Diseases of the nervous 
system”. The y- and x-axes depict the probability and number of shared 
variants, respectively; red arrows indicate the value observed. 
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Supplementary Figure Legends 
Figure S1. Data and RR thresholds. (a) Description of the study 
population and SIDIAP-Q dataset. (b) Graph depicting the top and bottom 
vigintiles of RR thresholds, by gender and stratum. 
 
Figure S2. Networks and small-word-ness. Small-world-ness property; 
all networks had values of S∆  > 1, which defines the threshold for the property. 
 
Figure S3. Central nodes attack. Plots showing the number of network 
components resulting from eliminating central nodes in each disease network 
by age and gender, or equivalent random sets of diseases (whisker plots show 
the average (orange colored stroke) and 95% CI in each setting). Observed 
higher numbers of network components relative to random attacks (empirical P 
values < 0.005) are indicated by colored age groups. 
 
Figure S4. Cumulative risks. Age-based trajectories of the RR sums for all 
diseases studied. Left and right panels show diseases linked by RRs > 1 and 
RRs < 1, respectively; top and bottom panels show results for men and women, 
respectively. 
 
Figure S5. Average cumulative RR trend distributions. Trends for 
disease sets classified as central, community roots, or with large degree leaps, 
and using the average RR cumulative risks. The results are similar to those 
depicted in Fig. 4; that is, central diseases and those with large degree leaps 
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show greater cumulative risks relative to the rest of diseases. Conversely, 
particularly in women, diseases classified as community roots have lower 
cumulative risks. Central and root diseases are marked in the insets, and the 
arrows indicate differences in each setting. 
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